Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000808 citationsPatrick L. Fitzgibbons, Donald L. Weaver et al.Archives of Pathology & Laboratory Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Simpson Jf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simpson Jf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simpson Jf more than expected).
This network shows the impact of papers produced by Simpson Jf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simpson Jf. The network helps show where Simpson Jf may publish in the future.
Co-authorship network of co-authors of Simpson Jf
This figure shows the co-authorship network connecting the top 25 collaborators of Simpson Jf.
A scholar is included among the top collaborators of Simpson Jf based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Simpson Jf. Simpson Jf is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
12 of 12 papers shown
1.
Jf, Simpson, et al.. (2006). Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.. PubMed. 19(6). 39–43.8 indexed citations
2.
Fitzgibbons, Patrick L., Donald L. Weaver, AD Thor, et al.. (2000). Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.. Archives of Pathology & Laboratory Medicine. 124(7). 966–78.808 indexed citations breakdown →
3.
Dl, Page, et al.. (1998). Premalignant and malignant disease of the breast: the roles of the pathologist.. PubMed. 11(2). 120–8.32 indexed citations
4.
Jf, Simpson & Page Dl. (1996). The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer.. PubMed. 23(4). 428–35.13 indexed citations
5.
Mj, Gaffey, Mills Se, Frierson Hf, et al.. (1995). Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.. PubMed. 8(1). 31–8.33 indexed citations
6.
Jf, Simpson & Page Dl. (1994). Status of breast cancer prognostication based on histopathologic data.. PubMed. 102(4 Suppl 1). S3–8.41 indexed citations
7.
Mj, Gaffey, Frierson Hf, Mills Se, et al.. (1993). Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.. PubMed. 6(6). 721–8.58 indexed citations
8.
Jf, Simpson & Page Dl. (1993). Loss of expression of fodrin (a structural protein) in cystic changes of human breast.. PubMed. 68(5). 537–40.2 indexed citations
9.
Jf, Simpson, et al.. (1992). Invasion in vitro of malignant hamster brain tumor cells is influenced by the number of cells and the mode of malignant progression.. PubMed. 12(1). 12–23.11 indexed citations
10.
Jf, Simpson & Page Dl. (1992). Prognostic value of histopathology in the breast.. Seminars in Oncology. 19(3). 254–62.30 indexed citations
11.
Jf, Simpson, et al.. (1968). Fluorescent protein tracing in multiple sclerosis brain tissue.. PubMed. 18(3). 295–295.7 indexed citations
12.
Jf, Simpson, et al.. (1957). A quantitative method of lysozyme determination. I. An investigation of bronchial lysozyme.. PubMed. 49(1). 145–50.14 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.